Antisense effects in the cell nucleus: Modification of splicing

Current Opinion in Molecular Therapeutics

Volumn 3, Issue 3, 2001, Pages 229-234

  Kole, R ^a   Sazani, P ^a  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

Antisense oligonucleotides; Gene expression; RNA processing

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BETA GLOBIN; LUCIFERASE; MESSENGER RNA; MESSENGER RNA PRECURSOR; RNA; TAU PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BECKER MUSCULAR DYSTROPHY; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DEMENTIA; DRUG ACTIVITY; DRUG DESIGN; DUCHENNE MUSCULAR DYSTROPHY; GENE EXPRESSION REGULATION; GENE MUTATION; GENE TARGETING; GENE THERAPY; GENETIC REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PARKINSONISM; RAT; RNA SPLICING; THALASSEMIA;

ALTERNATIVE SPLICING; ANIMALS; CELL NUCLEUS; GENE EXPRESSION REGULATION; GENETIC DISEASES, INBORN; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; THIONUCLEOTIDES;

ANIMALIA; MAMMALIA;

EID: 0034945672     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Progress in antisense technology: The end of the beginning
2. Morpholino antisense oligomers: The case for an RNase H-independent structural type
3. Phosphoramidate oligonucleotides as potent antisense molecules in cells and in vivo
4. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides
5. Eukaryotic mRNA processing
6. Drosophila Dscam is an axon guidance receptor exhibiting extraordinary molecular diversity
7. The Sequence of the Human Genome
8. Initial sequencing and analysis of the human genome
9. Alternative pre-mRNA splicing: The logic of combinatorial control
10. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences
11. Modification of alternative splicing of pre-mRNA by antisense oligonucleotides
12. Modification of alternative splicing pathways as a potential approach to chemotherapy
13. Thalassemia syndromes
14. Restoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patients
15. A common human β-globin splicing mutation modeled in mice
16. Stable alteration of pre-mRNA splicing patterns by modified U7 small nuclear RNAs
17. Double-target antisense U7 snRNAs promote efficient skipping of an aberrant exon in three human β-thalassemic mutations
18. Restoration of correct splicing of thalassemic β-globin pre-mRNA by modified U1 snRNAs
19. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations
20. Correction of aberrant splicing of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by antisense oligonucleotides
21. Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population
22. The spectrum of cystic fibrosis mutations
23. Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides
24. Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse
25. The molecular basis for Duchenne versus Becker muscular dystrophy: Correlation of severity with type of deletion
26. Exon structure of the human dystrophin gene
27. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: Differential expression of tau protein mRNAs in human brain
28. Molecular thanatopsis: A discourse on the BCL2 family and cell death
29. Bcl-2-family proteins: The role of the BH3 domain in apoptosis
30. Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides
31. Modification of alternative splicing of Bcl-x pre-mRNA induces apoptosis in prostate and breast cancer cells: Analysis of apoptosis and cell death
32. Antisense morpholino oligonucleotide analog induces missplicing of C-myc mRNA
33. Deletion of individual exons and induction of soluble murine interleukin-5 receptor-α chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing
34. Altered mRNA splicing and inhibition of human E-selectin expression by an antisense oligonucleotide in human umbilical vein endothelial cells
35. Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus
36. Antisense oligonucleotides with different backbones. Modification of splicing pathways and efficacy of uptake
37. Up-regulation of luciferase gene expression with antisense oligonucleotides: Implications and applications in functional assay development
38. Nuclear antisense effects of neutral, anionic and cationic oligonucleotides